DiBiase Mary 4
4 · X4 Pharmaceuticals, Inc · Filed Nov 9, 2022
Insider Transaction Report
Form 4
DiBiase Mary
Chief Operating Officer
Transactions
- Award
Stock Appreciation Right
2022-11-07+1,350,000→ 1,350,000 totalExercise: $1.80Exp: 2032-11-07→ Common Stock (1,350,000 underlying)
Footnotes (1)
- [F1]The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of November 7, 2022, subject to the Reporting Person remaining an employee of the Issuer through and including each applicable vesting date.